NCT02932280 2025-12-05Safety and Dose Finding Study of Neratinib in Children and Young Adults With Cancer That Has Returned or Not Responded to TreatmentMemorial Sloan Kettering Cancer CenterPhase 1/2 Active not recruiting14 enrolled
NCT00823524 2013-02-20Donor Natural Killer Cells After Donor Stem Cell Transplant in Treating Patients With Advanced CancerAsan Medical CenterPhase 1/2 Completed47 enrolled